Operator and Institutional Requirements for Transcatheter Mitral Valve Therapies in Australia: a CSANZ and ANZSCTS Position Statement

Iung, 2003, A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease, Eur Heart J, 24, 1231, 10.1016/S0195-668X(03)00201-X Mehta, 2019, Twelve-month healthcare utilization and expenditures in Medicare fee-for-service patients with clinically significant mitral regurgitation, J Comp Eff Res, 8, 1089, 10.2217/cer-2019-0026 Nkomo, 2006, Burden of valvular heart diseases: a population-based study, Lancet, 368, 1005, 10.1016/S0140-6736(06)69208-8 Baumgartner, 2017, 2017 ESC/EACTS Guidelines for the management of valvular heart disease, Eur Heart J, 38, 2739, 10.1093/eurheartj/ehx391 Otto, 2020, 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, J Am Coll Cardiol, 77, e25, 10.1016/j.jacc.2020.11.018 Bach, 2009, Failure of guideline adherence for intervention in patients with severe mitral regurgitation, J Am Coll Cardiol, 54, 860, 10.1016/j.jacc.2009.03.079 Dziadzko, 2018, Outcome and undertreatment of mitral regurgitation: a community cohort study, Lancet, 391, 960, 10.1016/S0140-6736(18)30473-2 Mirabel, 2007, What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?, Eur Heart J, 28, 1358, 10.1093/eurheartj/ehm001 Acker, 2014, Mitral-valve repair versus replacement for severe ischemic mitral regurgitation, N Engl J Med, 370, 23, 10.1056/NEJMoa1312808 Goldstein, 2016, Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation, N Engl J Med, 374, 344, 10.1056/NEJMoa1512913 Michler, 2016, Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation, N Engl J Med, 374, 1932, 10.1056/NEJMoa1602003 Obadia, 2018, Percutaneous repair or medical treatment for secondary mitral regurgitation, N Engl J Med, 379, 2297, 10.1056/NEJMoa1805374 Stone, 2018, Transcatheter mitral-valve repair in patients with heart failure, N Engl J Med, 379, 2307, 10.1056/NEJMoa1806640 Sorajja, 2016, Initial experience with commercial transcatheter mitral valve repair in the United States, J Am Coll Cardiol, 67, 1129, 10.1016/j.jacc.2015.12.054 Lim, 2019, Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP Study, JACC Cardiovasc Interv, 12, 1369, 10.1016/j.jcin.2019.04.034 Siminiak, 2012, Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial, Eur J Heart Fail, 14, 931, 10.1093/eurjhf/hfs076 Muller, 2017, Tendyne Global Feasibility Trial Investigators. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: A global feasibility trial, J Am Coll Cardiol, 69, 381, 10.1016/j.jacc.2016.10.068 Sorajja, 2019, Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients, J Am Coll Cardiol, 731250 Bapat, 2018, Early experience with new transcatheter mitral valve replacement, J Am Coll Cardiol, 71, 12, 10.1016/j.jacc.2017.10.061 Bonow, 2020, J Am Coll Cardiol, 76, 96, 10.1016/j.jacc.2019.12.002 Nishimura, 2019, J Am Coll Cardiol, 73, 2609, 10.1016/j.jacc.2018.10.007 Badhwar, 2020, Volume-outcome association of mitral valve surgery in the United States, JAMA Cardiol, 5, 1092, 10.1001/jamacardio.2020.2221 Chikwe, 2017, Relation of mitral valve surgery volume to repair rate, durability, and survival, J Am Coll Cardiol, 10.1016/j.jacc.2017.02.026 Vemulapalli, 2019, Procedural volume and outcomes for transcatheter aortic-valve replacement, N Engl J Med, 380, 2541, 10.1056/NEJMsa1901109 Chhatriwalla, 2019, Institutional experience with transcatheter mitral valve repair and clinical outcomes: insights from the TVT Registry, JACC Cardiovasc Interv, 12, 1342, 10.1016/j.jcin.2019.02.039 Stone, 2019, Volume-outcome relationships for transcatheter mitral valve repair: more is better, JACC Cardiovasc Interv, 12, 1353, 10.1016/j.jcin.2019.05.008 Bavry, 2020, Perspective to 2020 AHA/ACC Guideline for the management of patients with valvular heart disease, Circulation, 143, 407, 10.1161/CIRCULATIONAHA.120.051501 Asmarats, 2018, Transcatheter tricuspid valve interventions: landscape, challenges, and future directions, J Am Coll Cardiol, 71, 2935, 10.1016/j.jacc.2018.04.031